Hepatic Effects of Oral Contraceptives
- 9 February 1967
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 276 (6), 331-334
- https://doi.org/10.1056/nejm196702092760607
Abstract
BOTH the estrogen and progestogen in most of the oral contraceptive agents are 17-α-alkyl-substituted steroids.1 Because compounds of this structure may produce cholestasis2 , 3 it is not surprising that disturbed liver function has been reported in patients using oral contraceptives. The purpose of this report is to review the subject of the hepatic dysfunction induced by these agents, and to consider both the possible pathogenesis of the disturbance and its clinical implications.Clinical ReportsAbout 40 cases of jaundice attributed to 5 different oral contraceptives have been reported. Although most of the initial reports were from Scandinavia4 5 6 7 8 9 10 11 12 reports from England,13 , 14 Canada, . . .This publication has 33 references indexed in Scilit:
- Seven Cases of Jaundice in Women Taking an Oral Contraceptive, AnovlarBMJ, 1966
- Jaundice During Treatment With Oral Contraceptive AgentsJAMA, 1965
- Oral Contraception and Liver-function TestsBMJ, 1965
- Oral Contraceptives and Liver DamageBMJ, 1965
- Jaundice During Treatment with an Oral Contraceptive LyndiolBMJ, 1965
- Oral Contraception and Liver DamageBMJ, 1964
- Oral Contraceptives and Liver DamageBMJ, 1964
- Oral Contraceptives and Liver DamageBMJ, 1964
- Newer Drugs in Oral ContraceptionMedical Clinics of North America, 1964
- PHARMACOLOGY OF HEPATOTOXIC AGENTSAnnals of the New York Academy of Sciences, 1963